Local thermal ablative therapies for extracranial oligometastatic disease of non-small-cell lung cancer

被引:2
|
作者
Kong, Yongmei [1 ,2 ,3 ]
Xu, Hui [1 ,2 ,3 ]
Huang, Yahan [1 ,2 ,3 ]
Wei, Zhigang [1 ,2 ]
Ye, Xin [1 ,2 ]
机构
[1] Shandong First Med Univ, Affiliated Hosp 1, Dept Oncol, Jinan 250000, Shandong, Peoples R China
[2] Shandong Prov Qianfoshan Hosp, Shandong Lung Canc Inst, Shandong Key Lab Rheumat Dis & Translat Med, Jinan 250000, Shandong, Peoples R China
[3] Shandong First Med Univ, Jinan, Peoples R China
基金
中国国家自然科学基金;
关键词
extracranial; non-small cell lung cancer; oligometastatic diseases; thermal ablation; RADIOFREQUENCY ABLATION; MICROWAVE ABLATION; CLASSIFICATION; RADIOTHERAPY; METASTASIS; OUTCOMES; TUMOR; CHEMOTHERAPY; METAANALYSIS; MULTICENTER;
D O I
10.1111/ajco.13766
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Clinically, 40-50% of patients with NSCLC are found to have systemic metastasis at the initial diagnosis. Meanwhile, 30-75% of patients with lung cancer who have undergone radical surgical resection have local recurrence and distant metastases. However, not all distant metastases are multiple, and some are potentially curable. In this study, among the patients with NSCLC having distant organ metastasis, approximately 7% showed extrapulmonary solitary metastasis and remained in this relatively stable state for a long time. This form of metastasis is known as NSCLC oligometastases. This review describes the concept and classification of oligometastases, as well as the local treatment and prognosis of extracranial oligometastases.
引用
收藏
页码:3 / 8
页数:6
相关论文
共 50 条
  • [21] Efficacy and safety of microwave ablation in the treatment of patients with oligometastatic non-small-cell lung cancer: a retrospective study
    Wei, Zhigang
    Ye, Xin
    Yang, Xia
    Huang, Guanghui
    Li, Wenhong
    Han, Xiaoying
    Wang, Jiao
    Meng, Min
    Ni, Yang
    Li, Qingyu
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2019, 36 (01) : 827 - 834
  • [22] Systemic therapies in the treatment of non-small-cell lung cancer brain metastases
    Lukas, Rimas V.
    Kumthekar, Priya
    Rizvi, Syeda
    Salgia, Ravi
    FUTURE ONCOLOGY, 2016, 12 (08) : 1045 - 1058
  • [23] Utility of stereotactic ablative radiotherapy/stereotactic body radiation therapy in the setting of oligometastatic non-small cell lung cancer
    Song, Andrew
    Lu, Bo
    JOURNAL OF THORACIC DISEASE, 2018, 10 (02) : 657 - 660
  • [24] The Role of Surgery for Oligometastatic Non-Small Cell Lung Cancer
    Euhus, Caleb J.
    Ripley, Taylor R.
    Medina, Cristian G.
    CANCERS, 2022, 14 (10)
  • [25] Oligometastatic non-small-cell lung cancer: local treatment options for pulmonary and adrenal metastases
    Guckenberger, Matthias
    Lehmann, Kuno
    Opitz, Isabelle
    ONKOLOGE, 2020, 26 (09): : 800 - 815
  • [26] Antiangiogenic therapies in non-small-cell lung cancer
    Alshangiti, A.
    Chandhoke, G.
    Ellis, P. M.
    CURRENT ONCOLOGY, 2018, 25 : S45 - S58
  • [27] Emerging therapies in non-small-cell lung cancer
    Khuri, FR
    Herbst, RS
    Fossella, FV
    ANNALS OF ONCOLOGY, 2001, 12 (06) : 739 - 744
  • [28] Exhaustive preoperative staging increases survival in resected adrenal oligometastatic non-small-cell lung cancer: a multicentre studyaEuro
    De Wolf, Julien
    Bellier, Jocelyn
    Lepimpec-Barthes, Francoise
    Tronc, Francois
    Peillon, Christophe
    Bernard, Alain
    Le Rochais, Jean-Philippe
    Tiffet, Olivier
    Sage, Edouard
    Chapelier, Alain
    Porte, Henri
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2017, 52 (04) : 698 - 703
  • [29] Oligometastatic non-small-cell lung cancer: current treatment strategies
    Richard, Patrick J.
    Rengan, Ramesh
    LUNG CANCER-TARGETS AND THERAPY, 2016, 7 : 129 - 140
  • [30] Local Consolidative Therapy for Oligometastatic Non-Small Cell Lung Cancer
    Santos, Patricia Mae G.
    Li, Xingzhe
    Gomez, Daniel R.
    CANCERS, 2022, 14 (16)